留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究

王翔,  张梁宇,  丁宝月,  陈杨

downloadPDF
文章导航 > 药学实践与服务  > 2016 >  34(2): 148-152
王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
引用本文: 王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu
WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
Citation: WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu

新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究

doi: 10.3969/j.issn.1006-0111.2016.02.013
  • 1.

    解放军98医院, 浙江 湖州 313000

  • 2.

    嘉兴学院医学院, 浙江 嘉兴 314001

基金项目: 国家自然科学基金(81201809);南京军区科技创新重点项目(12Z03);全军医学科技青年培育项目(13QNP045)

Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study

  • 1.

    No.98 Hospital of PLA, Huzhou 313000, China

  • 2.

    School of Medicine, Jiaxing College, Jiaxing 310014, China

  • 摘要: 目的 制备新型喜树碱纳米凝胶给药系统(CPT-PPO gel),并对其含量、理化性质和体外透皮特性进行考察。 方法 以乙交酯-丙交酯共聚物(PLGA)包裹抗银屑病药物喜树碱(CPT)作为纳米系统的核,将聚酰胺-胺(PAMAM,G3.0)包裹在PLGA表面作为纳米系统的壳,采用乳化溶剂挥发法制备载喜树碱纳米系统(CPT-PLGA-PAMAM, CPT-PP),并用油酸(OA)进行修饰,得到经表面改性的核壳纳米给药系统(CPT-PLGA-PAMAM-OA, CPT-PPO)。采用HPLC法测定纳米乳中喜树碱的含量,采用透射电镜和激光粒径测定仪分别考察纳米粒的形态和粒径。以羟丙甲基纤维素(HPMC)为基质,制备CPT-PPO gel,并采用Franz扩散池对其体外透皮特性进行考察。 结果 制得的CPT-PPO gel平均粒径为(246.7±5.4) nm,包封率为(78.7±6.9)%,含量稳定,在4℃时具有良好的稳定性。体外透皮实验表明,纳米凝胶CPT-PPO gel、CPT-PP gel比普通凝胶CPT gel有更高的皮肤渗透量和滞留量(P<0.01),且CPT-PPO gel在皮肤渗透量和滞留量上均显著高于CPT-PP gel(P<0.05)。 结论 经过OA修饰的CPT-PPO gel可以显著提高药物的皮肤吸收量和滞留量,有望成为应用CPT局部治疗银屑病的新剂型。
    Abstract: Objective To prepare a novel drug delivery system camptothecin loaded nanogel(CPT-PPO gel), and investigate its contents, physical and chemical properties and in vitro transdermal permeability. Methods The solvent evaporation method was utilized to prepare core-shell nano-drug delivery systems(CPT-PLGA-PAMAM, CPT-PP), in which the Poly lactic-co-glycolic acid(PLGA) was used to load camptothecin as the nucleus and the polyamidoamine(PAMAM) G3.0 was wrapped in the surface of PLGA as the shell. Then the oleic acid(OA) was connected to CPT-PP to obtain the surface modified drug delivery system(CPT-PLGA-PAMAM OA, CPT-PPO). HPLC was used to determine the content of camptothecin in nanoparticles, transmission electron microscopy was applied to identify the nanoparticles morphology, and laser analyzer was used to determine the particle size. The hydroxypropyl methylcellulose(HPMC) was added as the base for the preparation of the nanogel(CPT-PPO gel) at last. The Franz-diffusion cell was used to determine the permeation rate of nanogel in vitro. Results The resulting CPT-PPO gel was stable at 4℃, the average particle size was(246.7±5.4) nm and the encapsulation efficiency was up to(78.7±6.9)%. Comparing to the normal gel,(CPT gel), the cumulative penetration amount and the retention amount in the skin of the nanogels(CPT-PPO gel,CPT-PP gel) were significant higher(P<0.01), the retention and cumulative penetration amount of CPT-PPO gel was significant higher than that of CPT-PP gel(P<0.05). Conclusion After modified by OA, CPT-PPO gel can increase the cumulated amount and absorption in skin and can be used as a carrier of CPT in the new formulation for topical treatment of psoriasis.
  • [1] Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery[J]. Eur J Pharm Sci, 2001, 14(2):101-114.
    [2] Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery[J]. Adv Drug Deliv Rev, 2011, 63(6):470-491.
    [3] Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis[J]. Chem Phys Lipids, 2012, 165(4):454-461.
    [4] Bachhav YG, Mondon K, Kalia YN, et al. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals[J]. J Control Release, 2011, 153(2):126-132.
    [5] Vijayan V, Reddy KR, Sakthivel S, et al. Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs:in vitro and in vivo studies[J]. Colloids Surf B Biointerfaces, 2013, 1(111):150-155.
    [6] Agrawal U, Mehra NK, Gupta U et al. Hyperbranched dendritic nano-carriers for topical delivery of dithranol[J]. J Drug Target,2013, 21(5):497-506.
    [7] Chen Y, Wang M, Fang L. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems[J]. Drug Deliv, 2013, 20(5):199-209.
    [8] Rancan F, Papakostas D, Hadam S, et al. Investigation of polylactic acid(PLA) nanoparticles as drug delivery systems for local dermatotherapy[J]. Pharm Res, 2009, 26(8):2027-2036.
    [9] Shah PP, Desai PR, Channer D, et al. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers[J]. J Controlled Release, 2012, 161(3):735-745.
    [10] Shah PP, Desai PR, Patel AR, et al. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs[J]. Biomaterials, 2012, 33(5):1607-1617.
    [11] Yang Y, Sunoqrot S, Stowell C, et al. Effect of size, surface charges, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration[J]. Biomacromolecules,2012, 13(7):2154-2162.
    [12] O'Leary J, Muggia FM. Camptothecins:a review of their development and schedules of administration[J]. Eur J Cancer, 1998,34(10):1500-1508.
    [13] Min KH, Park K, Kim YS, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy[J]. J Control Release,2008, 127(3):208-218.
    [14] Andrew J. Jennifer K. Carmen J, et al. Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors[J]. Drug Deliv Transl Res,2011,1(1):34-42.
    [15] Castillo PM, de la Mata M, Casula MF, et al. PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system[J]. Beilstein J Nanotechnol, 2014, 5:1312-1319.
    [16] Zhang L, Hu Y, Jiang X, et al. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice[J]. J Control Release, 2004, 96(1):135-148.
    [17] Botella P, Abasolo I, Fern ndez Y, et al. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation[J].J Control Release,2011,156(2):246-257.
  • [1] 陈昕璐, 高原, 李鹃鹃, 郭欢欢, 王卓, 高申.  mRNA脂质纳米粒载药系统的构建及体外评价 . 药学实践与服务, 2023, 41(5): 291-295. doi: 10.12206/j.issn.2097-2024.202302026
    [2] 戴玮莉, 金婴, 王婷, 唐晓萌, 顾清.  盐酸小檗碱纳米乳口服给药系统的制备及体外评价 . 药学实践与服务, 2022, 40(1): 28-33, 43. doi: 10.12206/j.issn.1006-0111.202107081
    [3] 顾清, 周剑斌, 徐剑良, 朱国花, 舒薇.  基于微透析技术的苦参碱凝胶经皮给药的药动学研究 . 药学实践与服务, 2019, 37(6): 503-507. doi: 10.3969/j.issn.1006-0111.2019.06.006
    [4] 陈丽娜, 陈建明.  难溶性药物logP值对纳米脂肪乳载药特性的影响 . 药学实践与服务, 2015, 33(6): 513-517. doi: 10.3969/j.issn.1006-0111.2015.06.009
    [5] 崔晓如, 关晓多, 缪震元, 张万年, 范国荣.  高喜树碱衍生物10-羟基-7-甲基-高喜树碱的电喷雾离子阱质谱分析 . 药学实践与服务, 2013, 31(1): 24-26,60. doi: 10.3969/j.issn.1006-0111.2013.01.007
    [6] 王晓宇, 高静, 张玮, 朱全刚, 武鑫, 高申.  细胞外激活纳米载药系统研究进展 . 药学实践与服务, 2012, 30(1): 4-7,57. doi: 10.3969/j.issn.1006-0111.2012.01.002
    [7] 万展, 周剑, 韩美娜, 杨峰.  微针透皮给药系统应用研究进展 . 药学实践与服务, 2012, 30(2): 86-88,142. doi: 10.3969/j.issn.1006-0111.2012.02.002
    [8] 陈婷, 鲁莹.  载抗肿瘤药物纳米靶向给药系统的研究进展 . 药学实践与服务, 2011, 29(3): 176-178,196.
    [9] 陈建明, 杨秋霞.  纳米给药系统在军队特需药品研究中的应用 . 药学实践与服务, 2010, 28(2): 81-83,93.
    [10] 王晶, 王晓黎, 欧伊益, 郭俊生.  氢溴酸东莨菪碱微乳的制备及其体外透皮吸收研究 . 药学实践与服务, 2009, 27(4): 279-281.
    [11] 高翔, 张晨曦, 杨明, 刘继勇.  盐酸西替利嗪凝胶剂的制备及体外透皮特性 . 药学实践与服务, 2009, 27(5): 367-369.
    [12] 任浩洋, 常红霞, 张明华, 王文刚.  非洛地平-硬脂酸固体脂质纳米粒的制备及其体外透皮吸收研究 . 药学实践与服务, 2008, (5): 346-349.
    [13] 孔令媛, 马骏.  液相色谱法测定羟基喜树碱含量及药动学研究 . 药学实践与服务, 2007, (6): 379-381.
    [14] 曹琴, 丁志建, 丁雪鹰, 高申.  非甾体抗炎药透皮给药的研究进展 . 药学实践与服务, 2003, (3): 147-149.
    [15] 王昌林, 周月芬, 李昱.  喜树碱类抗肿瘤药物研究概况 . 药学实践与服务, 2001, (3): 172-174.
    [16] 傅若秋, 李建平, 何凤慈.  酮洛芬凝胶的制备及体外透皮试验 . 药学实践与服务, 1999, (5): 288-290.
    [17] 朱杰, 张万年, 季海涛.  喜树碱类化合物的构效关系及作用方式研究 . 药学实践与服务, 1999, (2): 71-74.
    [18] 李晓红, 蒋晓明.  羟基喜树碱膀胱内灌注预防膀胱浅表肿瘤复发 . 药学实践与服务, 1998, (5): 276-277.
    [19] 黄胜炎.  透皮给药制剂品种进展 . 药学实践与服务, 1990, (1): 47-51.
    [20] S.W.Kim.  药物释放系统的水凝胶 . 药学实践与服务, 1986, (3): 62-63.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2967
  • HTML全文浏览量:  277
  • PDF下载量:  23
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-03-09
  • 修回日期:  2016-01-12

新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究

doi: 10.3969/j.issn.1006-0111.2016.02.013
  • 1. 解放军98医院, 浙江 湖州 313000
  • 2. 嘉兴学院医学院, 浙江 嘉兴 314001
    • 基金项目:  国家自然科学基金(81201809);南京军区科技创新重点项目(12Z03);全军医学科技青年培育项目(13QNP045)
  • 收稿日期: 2015-03-09
  • 修回日期: 2016-01-12

摘要: 目的 制备新型喜树碱纳米凝胶给药系统(CPT-PPO gel),并对其含量、理化性质和体外透皮特性进行考察。 方法 以乙交酯-丙交酯共聚物(PLGA)包裹抗银屑病药物喜树碱(CPT)作为纳米系统的核,将聚酰胺-胺(PAMAM,G3.0)包裹在PLGA表面作为纳米系统的壳,采用乳化溶剂挥发法制备载喜树碱纳米系统(CPT-PLGA-PAMAM, CPT-PP),并用油酸(OA)进行修饰,得到经表面改性的核壳纳米给药系统(CPT-PLGA-PAMAM-OA, CPT-PPO)。采用HPLC法测定纳米乳中喜树碱的含量,采用透射电镜和激光粒径测定仪分别考察纳米粒的形态和粒径。以羟丙甲基纤维素(HPMC)为基质,制备CPT-PPO gel,并采用Franz扩散池对其体外透皮特性进行考察。 结果 制得的CPT-PPO gel平均粒径为(246.7±5.4) nm,包封率为(78.7±6.9)%,含量稳定,在4℃时具有良好的稳定性。体外透皮实验表明,纳米凝胶CPT-PPO gel、CPT-PP gel比普通凝胶CPT gel有更高的皮肤渗透量和滞留量(P<0.01),且CPT-PPO gel在皮肤渗透量和滞留量上均显著高于CPT-PP gel(P<0.05)。 结论 经过OA修饰的CPT-PPO gel可以显著提高药物的皮肤吸收量和滞留量,有望成为应用CPT局部治疗银屑病的新剂型。

English Abstract

王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
引用本文: 王翔, 张梁宇, 丁宝月, 陈杨. 新型喜树碱纳米凝胶给药系统的构建及体外透皮特性研究[J]. 药学实践与服务, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu
WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
Citation: WANG Xiang, ZHANG Liangyu, DING Baoyue, CHEN Yang. Novel camptothecin loaded nanogel system: formulation optimization and in vitro transdermal permeability study[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 148-152. doi: 10.3969/j.issn.1006-0111.2016.02.013
shu

    全文HTML

参考文献 (17)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计